Switching therapy from metformin to a sulfonylurea increases the risk for adverse outcomes in patients with type 2 diabetes, new research suggests.
Results of a study using data from the UK Clinical Practice Research Datalink were published online July 18 in BMJ by epidemiologist Antonios Douros, MD,
I veckan kom resultaten för CARMELINA, se bifogad Press Release. CARMELINA är den kardiovaskulära utfallsstudien för Trajenta® (linagliptin).
Trajenta uppnådde det primära utfallsmåttet, non-inferiority för 3P-MACE (kardiovaskulär död, icke-fatal hjärtinfarkt och icke-fatal stroke). Trajenta är därav,
Carl Willers1,2*, Hanna Iderberg2,3, Mette Axelsen4, Tobias Dahlstro ̈ m5, Bettina Julin2, Janeth Leksell6, Agneta Lindberg7, Peter Lindgren3,8, Karin Loostro ̈ m Muth9, Ann- Marie Svensson10, Mikael Lilja11
Socioeconomic status, origin or demographic attributes shall not determine
FreeStyle Libre boosts testing adherence and lowers costs during MDI treatment, US study reports
The FreeStyle Libre lowers health costs and improves treatment adherence compared with self-monitoring of blood glucoselevels (SMBG), a US study shows.
The Libre and continuous glucose monitors devices
Som representant för Svensk förening för Diabetologi (SFD) har jag deltagit i juli deltagit i ett EU sponsrat möte i Berlin. Det handlade om patientens mål med vården och hur patienten själv kan bidra till bättre hälsa och livskvalitet. Här kommer en kort summering av mötet och mina reflektioner kring
There are 2 phases of C-peptide decline that occur during the first 4 decades following a diagnosis of type 1 diabetes (T1D), and further understanding of the pathophysiologic and immunologic differences between these two phases may help increase knowledge of β-cell survival, according to a study
Meta‐analyses and blood pressure goals
Editorial Staffan Björck, Karin Manhem, Annika Rosengren, Samuel Adamsson, Soffia Gudbjörnsdottrir, Stefan Franzén 
JCH Journal of Clinical Hypertension, offical journal of the world hyperetension league
published June 26 2018
Läs i full text hela artikeln utan
Dear Colleague,
As previously announced The Third Swedish Diabetes Summit will take place November 15-16 in Stockholm. We are very happy to invite you to this unique national diabetes research meeting with speakers from 7 different Swedish universities as well as several internationally recognized
Nationella riktlinjer för prevention och behandling vid ohälsosamma levnadsvanor – Stöd för styrning och ledning
Nu är de nationella riktlinjerna för prevention och behandling vid ohälsosamma levnadsvanor publicerade.
Riktlinjerna kommer att vara ett stöd för dem som fattar beslut om hur
Höga blodsockernivån kopplas till hjärtmissbildning
Kvinnor med typ 1-diabetes som planerar att bli gravida eller är i en tidig graviditetsfas bör hålla koll på sitt blodsocker. Höga nivåer ser nämligen ut att kunna ha ett samband med en ökad risk för hjärtmissbildningar hos barnen, visar ny
At the meeting the last ADA day Julio Rosenstock from Dallas prof of Medicine presented the empagliflozin results in T1 DM.
He said in the beginning that new insulin formulations and advanced delivery system with more precise CGM and sesnor-augmented insulin pumps (SAP) are just not enough to
 The treatment approach to type 2 diabetes should begin with an assessment of cardiovascular disease (CVD) status, other comorbidities, and patient preferences, according to a draft of the upcoming 2018 joint consensus statement from the American Diabetes Association (ADA) and European Association
Posters. Absteacts
FreeStyle Libre™ Use for Self-Management of Diabetes in Teenagers and Young Adults
Author FIONA  CAMPBELL, JAN BOLINDER, Leeds, United Kingdom, Stockholm, Sweden

The challenges of caring for diabetes in teenagers and young adults are well known. We analyzed two research studies
The Pros and Cons of Gastric Bypass Surgery in Obese Individuals with Type 2 Diabetes—Nationwide, Matched, Observational Cohort
Oral presentation
The Author Group received 1000 US dollar from ADA at a meeting yesterday for excellent study and the statistical model
Study abstract 

Long-term effects
TEDDY Trial Struggles to Identify Environmental Triggers of Type 1 Diabetes
The TEDDY study (make a Google) hypothesized that there are “triggers” that cause a child with high-risk genes for type 1 diabetes to actually get type 1, based on the observation that not all children who are at higher risk
Metformin Alone or Combined with Insulin Does Not Improve or Preserve Beta-Cell Function in Youth with Impaired Glucose Tolerance or Newly Diagnosed Type 2 Diabetes
Restoring Insulin Secretion (RISE) Pediatric Medication Study shows that youth have markedly reduced insulin sensitivity and respond
Diabetes is a unique and complex disease and the individual living with diabetes is solely responsible for daily diabetes management.
The added stress of this responsibility significantly increases their risk for depression and anxiety. 
Research has indicated that symptoms of depression have been shown to be
Basal Insulin Doesn't Cut Hypoglycemia Risk Vs NPH in T2D
Similar hypoglycemia-related emergency department and hospital admissions
Human neutral protamine Hagedorn (NPH) insulin and long-acting basal insulin came out on par for serious hypoglycemia risks in an observational study.
Medtronic 670G CE märkt
Igår meddelades CE märkning dvs insulinpump är godkänd i Europa och Sverige från 7 år och med  insulinbehov med minst 8 enh per dygn
670G är första hybrid closed loop HCL pump som finns på marknaden. Denna pump kan automatiskt stänga av insulintillförsel vid låga glukos och öka
ANNA MARIA LANGKILDE, ON BEHALF OF THE DEPICT-2 INVESTIGATORS, Leuven, Belgium, Buffalo, NY,  Edmonton, AB, Canada, Heidelberg, Germany, Kumamoto, Japan, Gothenburg, Sweden, Swansea, United
Analysis of European Steno 2 study examines long-term economic implications of interventions targeting complications
When patients with type 2 diabetes (T2D) receive intensified, multifactorial treatment combining lifestyle modification and pharmacological therapy for modifiable risk factors, there
Det är i år mycket fokus på teknik vid typ 1 diabetes.
1. Medtronic 670G hybrid closed loop pump (HCL pump) godkänd i USA igår av FDA även för barn 7-14 år. Tidigare sept 2016 godkänd for vuxna i USA.
Europa och Sverige väntar fortfarande på CE godkännande. 670G är den första kommersiella hybrid closed
This year there are no genuine major trial presented 2018 at the meeting, Instead, there are many real world diabetes observational studies.
Randomized controlled clinical trial (RCT) are the gold standard för establishing safety and efficacy of new diabetes treatments. But real world observations can
In a head-to-head trial comparing three currently available continuous glucose monitors (CGMs) for real-world use in diabetes, the newly approved implantable glucose monitor Eversense (Senseonics) performed the best.
Findings from the comparison of the 90-day Eversense with the 7-day Dexcom G5 (not